Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia

NCT05975996

Conditions: Anemia, Anemia, Aplastic, Bone Marrow Diseases, +4 more
Locations: Regenerative Medicine Center Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

NCT04398459

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations: Zhoukou Central Hospital Zhoukou, Henan, China

The Second Affilated Hospital of Shandong First Medical University Tai’an, Shandong, China

Regenerative Medicine Center Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation

NCT02990130

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations: VA Puget Sound Health Care System Seattle, Washington, United States

View Trial Details

Active, not recruiting

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

NCT03789981

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: AO Spedali Civili di Brescia Brescia, BS, Italy

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy

IRCCS Casa sollievo sofferenza San Giovanni Rotondo, FOGGIA, Italy

IRCCS AOU S. Martino Genova Genova, GE, Italy

View all 14 locations

View Trial Details

Active, not recruiting

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

NCT06145321

Conditions: Agranulocytosis, Cytopenia, Filgrastim, +9 more
Locations: Chang Gung Children Hospital Taoyuan, ROC, Taiwan

View Trial Details

Active, not recruiting

Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.

NCT03541083

Conditions: ALL, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: BE-Antwerpen Edegem-UZA Antwerp, Belgium

BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium

BE-Brugge-AZBRUGGE Bruges, Belgium

BE-Gent-UZGENT Ghent, Belgium

View all 18 locations

View Trial Details

Active, not recruiting

Project Baseline Health Study

NCT03154346

Conditions: ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Baseline Study South San Francisco, California, United States

Stanford Medicine Stanford, California, United States

California Health and Longevity Institute Westlake Village, California, United States

Duke University School of Medicine Durham, North Carolina, United States

View Trial Details

Active, not recruiting

Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

NCT03225417

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: ICO- Hospital Germans Trias i Pujol Badalona, Spain

Hospital Clinic de Barcelona Barcelona, Spain

Hospital de la Santa Creu I Sant Pau Barcelona, Spain

Hospital Universitario Vall D´Hebrón Barcelona, Spain

View Trial Details

Active, not recruiting

ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study

NCT04707235

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: Amiens - Picardie Hospital Adults Amiens, France

Amiens Picardie Hospital Children Amiens, France

Clinique de l'Europe Amiens Amiens, France

Angers Hospital Adults Angers, France

View all 87 locations

View Trial Details

Active, not recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

NCT06475820

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +19 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, Samory-Mashela,1, Russia

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions